Kymera Therapeutics, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Sep 2019 | $950.0K | $-11.9M | $-11.4M |
| Mar 2020 | $3.4M | $-11.2M | $-10.9M |
| Jun 2020 | $3.3M | $-14.2M | $-14.0M |
| Sep 2020 | $14.5M | $-8.1M | $-8.0M |
| Dec 2020 | $12.8M | $-12.8M | $-12.7M |
| Mar 2021 | $18.7M | $-13.2M | $-13.1M |
| Jun 2021 | $18.5M | $-24.7M | $-24.7M |
| Sep 2021 | $20.3M | $-28.6M | $-28.6M |
| Dec 2021 | $15.3M | $-34.0M | $-33.9M |
| Mar 2022 | $9.6M | $-36.9M | $-36.7M |
| Jun 2022 | $11.5M | $-40.8M | $-40.3M |
| Sep 2022 | $9.6M | $-44.9M | $-43.0M |
| Dec 2022 | $16.1M | $-38.6M | $-34.9M |
| Mar 2023 | $9.5M | $-45.3M | $-40.9M |
| Jun 2023 | $16.5M | $-43.4M | $-38.8M |
| Sep 2023 | $4.7M | $-57.5M | $-52.9M |
| Dec 2023 | $47.9M | $-19.3M | $-14.4M |
| Mar 2024 | $10.3M | $-57.8M | $-48.6M |
| Jun 2024 | $25.7M | $-50.9M | $-42.1M |
| Sep 2024 | $3.7M | $-72.1M | $-62.5M |
| Dec 2024 | $7.4M | $-80.8M | $-70.8M |
| Mar 2025 | $22.1M | $-74.4M | $-65.6M |
| Jun 2025 | $11.5M | $-84.6M | $-76.6M |
| Sep 2025 | $2.8M | $-92.5M | $-82.2M |
| Dec 2025 | $2.9M | $-97.9M | $-87.0M |
| Mar 2026 | $34.4M | $-84.2M | $-69.2M |
| Jun 2026 | $65.0M | $-75.6M | $-61.2M |